Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06317805
Status:
RECRUITING
Last Update Posted:
2024-03-19
First Post:
2024-02-20
Brief Title:
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Sponsor:
AOP Orphan Pharmaceuticals AG
Organization:
AOP Orphan Pharmaceuticals AG
Organization Data
Organization:
AOP Orphan Pharmaceuticals AG
Class:
INDUSTRY
Study ID:
TREV1-10P401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AOP Orphan Pharmaceuticals AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ANOVA CRO sro | UNKNOWN |
| PharmaLex Belgium | UNKNOWN |
| Aixial sro | UNKNOWN |
| GCP-Service International Ltd Co KG | INDUSTRY |